Loading…
Reported covered position: House Cmte on Energy and Commerce, Prof. Staff; Congressman Mary Bono, Leg. Asst.; Congressman Elton Gallegly, Leg. Asst.; Congressman Michael Bilirakis, Leg. Asst.; Congressman Michael Bilirakis, Leg. Corr.; Congressman Michael Bilirakis, Staff Asst
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to the conference report accompanying H.J. Res 31; issues related to the impact of the government shutdown on FDA.
Monitored issues related to the conference report accompanying H.J. Res 31.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2019 · third_quarter · Q3
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Source: Senate LDA
| SCAN HEALTH PLAN |
| 9 |
| 2017–2019 |
| SHIRE PHARMACEUTICALS LLC | 9 | 2017–2018 |
| BRISTOL-MYERS SQUIBB COMPANY | 8 | 2017–2019 |
| UCB, INC. | 8 | 2017–2019 |
| GILEAD SCIENCES, INC. | 3 | 2019 |
| AMERICAN DENTAL ASSOCIATION | 2 | 2017 |
Consolidated Appropriations Act, 2019
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Monitored issues related to the conference report accompanying H.J. Res 31.
Workplace Violence Prevention for Health Care and Social Service Workers Act
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages; issues related to H.R. 1839, Medicaid Investment & Accountability Act; H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI); issues related to federal funding of research. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, and S. 1895, Lower Health Care Costs Act of 2019 as it relates to surprise billing.
Donald Payne Sr. Colorectal Cancer Detection Act of 2019
Client: GUARDANT HEALTH · Firm: THE NICKLES GROUP, LLC
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019.
Donald Payne Sr. Colorectal Cancer Detection Act of 2019
Client: GUARDANT HEALTH · Firm: THE NICKLES GROUP, LLC
Issues related to the regulation of laboratory developed tests and the VALID Act; monitored issues related to drug pricing; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019.
Medicaid Services Investment and Accountability Act of 2019
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug shortages; Issues related to H.R. 1839, Medicaid Investment & Accountability Act; H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI); issues related to federal funding of research.
Medicaid Services Investment and Accountability Act of 2019
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages; issues related to H.R. 1839, Medicaid Investment & Accountability Act; H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI); issues related to federal funding of research. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, and S. 1895, Lower Health Care Costs Act of 2019 as it relates to surprise billing.
Medicaid Services Investment and Accountability Act of 2019
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation; monitored issues related to H.R. 1839, Medicaid Services Investment and Accountability Act of 2019; issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Medicaid Services Investment and Accountability Act of 2019
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation; monitored issues related to H.R. 1839, Medicaid Services Investment and Accountability Act of 2019.
More Efficient Tools to Realize Information for Consumers Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2593, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
More Efficient Tools to Realize Information for Consumers Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Monitored H.R. 2296, METRIC Act of 2019. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues related to Pandemic and All-Hazards Preparedness. S. 1379 / H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPA). S. 1895, Lower Health Care Costs Act of 2019. Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation; monitored issues related to H.R. 1839, Medicaid Services Investment and Accountability Act of 2019; issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Newborn Screening Saves Lives Reauthorization Act of 2019
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Monitored issues related to drug pricing; S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to value-based payment; issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug shortages; Issues related to H.R. 1839, Medicaid Investment & Accountability Act; H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI); issues related to federal funding of research.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Monitored H.R. 2296, METRIC Act of 2019. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues related to Pandemic and All-Hazards Preparedness. S. 1379 / H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPA). S. 1895, Lower Health Care Costs Act of 2019. Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. Issues related to Pandemic and All-Hazards Preparedness. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPA); monitored issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages; issues related to H.R. 1839, Medicaid Investment & Accountability Act; H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI); issues related to federal funding of research. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, and S. 1895, Lower Health Care Costs Act of 2019 as it relates to surprise billing.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Monitored H.R. 2296, METRIC Act of 2019. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues related to Pandemic and All-Hazards Preparedness. S. 1379 / H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPA). S. 1895, Lower Health Care Costs Act of 2019. Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2593, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home.
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
Issues related to fall prevention. H.R. 3461, Community-Based Independence for Seniors Act of 2019.
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
Issues related to Community Based Independence for Seniors; issues related to drug pricing and the implementation of the blueprint to lower drug prices & reduce out of pocket costs; issues related to the safe harbor protection; issues related to fall prevention. H.R. 3461, Community-Based Independence for Seniors Act of 2019.
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages; issues related to H.R. 1839, Medicaid Investment & Accountability Act; H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI); issues related to federal funding of research. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, and S. 1895, Lower Health Care Costs Act of 2019 as it relates to surprise billing.
Issues related to the regulation of laboratory developed tests and the VALID Act; monitored issues related to drug pricing; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019.
End Surprise Billing Act of 2019
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019.
End Surprise Billing Act of 2019
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019 and No Surprises Act discussion draft; H.R. 861, End Surprise Billing Act of 2019.
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019.
Issues related to drug pricing including transparency; monitored H.R. 965, the CREATES Act; monitored healthcare consolidation.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Monitored H.R. 2296, METRIC Act of 2019. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues related to Pandemic and All-Hazards Preparedness. S. 1379 / H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPA). S. 1895, Lower Health Care Costs Act of 2019. Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Lower Health Care Costs Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Monitored H.R. 2296, METRIC Act of 2019. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues related to Pandemic and All-Hazards Preparedness. S. 1379 / H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPA). S. 1895, Lower Health Care Costs Act of 2019. Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Lower Health Care Costs Act
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019 and No Surprises Act discussion draft; H.R. 861, End Surprise Billing Act of 2019.
Monitored issues related to the regulation of laboratory developed tests and the VALID Act; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019.
Lower Health Care Costs Act
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages; issues related to H.R. 1839, Medicaid Investment & Accountability Act; H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI); issues related to federal funding of research. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, and S. 1895, Lower Health Care Costs Act of 2019 as it relates to surprise billing.
Issues related to the regulation of laboratory developed tests and the VALID Act; monitored issues related to drug pricing; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019.
Lower Health Care Costs Act
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019.
Lower Health Care Costs Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2593, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Prescription Drug Pricing Reduction Act of 2019
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Monitored issues related to drug pricing; S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to value-based payment; issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
End Government Shutdowns Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2593, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Establishing the congressional budget for the United States Government for fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028.
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
Monitored the FY 2019 budget resolution, H. Con. Res. 128.
H.R. 1892, Bipartisan Budget Act of 2018 and issues related to Medicare reimbursement for prescription drugs; monitored H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to drug pricing; issue related to value-based pricing.
Consolidated Appropriations Act, 2018
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE NICKLES GROUP, LLC
H.R. 1625, Consolidated Appropriations Act of 2018. H.R. 1892, Bipartisan Budget Act of 2018 and issues concerning the home infusion benefit.
Issues related to value based purchasing; issues related to reimbursement of Part B drugs; monitored H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Part D program.
Consolidated Appropriations Act, 2018
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. H.R. 1625, Consolidated Appropriations Act of 2018. H.R. 1892, Bipartisan Budget Act of 2018. Issues related to the Puerto Rico recovery efforts. Issues related to ESRD payment.
Consolidated Appropriations Act, 2018
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, H.R. 3178, Medicare Part B Improvement Act of 2017, H.R. 1892, Bipartisan Budget Act of 2018 and issues regarding care for chronic diseases, including telehealth issues such as home as originating site and remote monitoring of home dialysis patients. Issues related to ESRD PPS. H.R. 1625, Consolidated Appropriations Act of 2018.
Consolidated Appropriations Act, 2018
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare extenders and hospital reimbursement.
Consolidated Appropriations Act, 2018
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
H.R. 1892, Bipartisan Budget Act of 2018; H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to drug pricing.
Consolidated Appropriations Act, 2018
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to the Independent Payment Authority Board; H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to regulatory relief; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment; H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare reimbursement.
Consolidated Appropriations Act, 2018
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, H.R. 1892, Bipartisan Budget Act of 2018 and issues regarding extension of the Independence at Home Demo, and expansion of telehealth services in certain ACOs and for individuals with stroke. Issues regarding wellness policies. Issues related to regulatory relief. H.R. 2556, the CONNECT for Health Act of 2017, regarding telehealth services for individuals with stroke. H.R. 1625, Consolidated Appropriations Act of 2018.
Consolidated Appropriations Act, 2018
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
H.R. 1892, Bipartisan Budget Act of 2018 and H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare.
Consolidated Appropriations Act, 2018
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
Issues related to value based purchasing; H.R. 1892, Bipartisan Budget Act of 2018 and H.R. 1625, Consolidated Appropriations Act of 2018, regarding drug pricing; monitored the Medicare NCD on NGS related LDT's.
Consolidated Appropriations Act, 2018
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE NICKLES GROUP, LLC
H.R. 1892, Bipartisan Budget Act, H.R. 3178, Medicare Part B Improvement Act of 2017, and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to reimbursement for home infusion. Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list. H.R. 1625, Consolidated Appropriations Act of 2018.
Bipartisan Budget Act of 2018
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to the Independent Payment Authority Board; H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to regulatory relief; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment; H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare reimbursement.
Bipartisan Budget Act of 2018
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, H.R. 1892, Bipartisan Budget Act of 2018 and issues regarding extension of the Independence at Home Demo, and expansion of telehealth services in certain ACOs and for individuals with stroke. Issues regarding wellness policies. Issues related to regulatory relief. H.R. 2556, the CONNECT for Health Act of 2017, regarding telehealth services for individuals with stroke. H.R. 1625, Consolidated Appropriations Act of 2018.
H.R. 1892, Bipartisan Budget Act of 2018 and H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare.
Bipartisan Budget Act of 2018
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
Issues related to value based purchasing; H.R. 1892, Bipartisan Budget Act of 2018 and H.R. 1625, Consolidated Appropriations Act of 2018, regarding drug pricing; monitored the Medicare NCD on NGS related LDT's.
Bipartisan Budget Act of 2018
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE NICKLES GROUP, LLC
H.R. 1892, Bipartisan Budget Act, H.R. 3178, Medicare Part B Improvement Act of 2017, and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to reimbursement for home infusion. Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list. H.R. 1625, Consolidated Appropriations Act of 2018.
H.R. 1892, Bipartisan Budget Act of 2018 and issues related to Medicare reimbursement for prescription drugs; monitored H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to drug pricing; issue related to value-based pricing.
Bipartisan Budget Act of 2018
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE NICKLES GROUP, LLC
H.R. 1625, Consolidated Appropriations Act of 2018. H.R. 1892, Bipartisan Budget Act of 2018 and issues concerning the home infusion benefit.
Issues related to value based purchasing; issues related to reimbursement of Part B drugs; monitored H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Part D program.
Bipartisan Budget Act of 2018
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
H.R. 1892, Bipartisan Budget Act of 2018; H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to drug pricing.
Bipartisan Budget Act of 2018
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
Monitored issues related to pharmaceutical prices. H.R. 1625, Consolidated Appropriations Act of 2018. H.R. 1892, Bipartisan Budget Act of 2018. Issues related to the Puerto Rico recovery efforts. Issues related to ESRD payment.
Bipartisan Budget Act of 2018
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, H.R. 3178, Medicare Part B Improvement Act of 2017, H.R. 1892, Bipartisan Budget Act of 2018 and issues regarding care for chronic diseases, including telehealth issues such as home as originating site and remote monitoring of home dialysis patients. Issues related to ESRD PPS. H.R. 1625, Consolidated Appropriations Act of 2018.
Bipartisan Budget Act of 2018
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare extenders and hospital reimbursement.
Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes.
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues related to opioid abuse; monitored Alexander Murray, The Bipartisan Healthcare Stabilization Act of 2017. Monitored H.R. 3545, The Overdose Prevention and Patient Safety Act. S. 1827, KIDS Act of 2017 and H.R. 195, Extension of Continuing Appropriations Act, 2018 as they relate to reauthorizaion of CHIP.
H.R. 2368, Right to Try Act. H.R. 878, Right to Try Act of 2017. H.R. 5247/ S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Issues regarding access to care for those with rare diseases.
Monitored issues related to H.R. 2368 and H.R. 878, The Right to Try Act of 2017 and S. 204 and H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Issues related to opioids and prescription drug monitoring programs including H.R. 5812, the CONNECTIONS Act.
Monitored issues related to Right to Try including H.R. 2368 and H.R. 878, Right to Try Act of 2017, and S. 204 and H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; S. 1827, The Keep Kids' Insurance Dependable and Secure Act of 2017, H.R. 3921, HEALTHY KIDS Act and issues related to prescription drugs.
Issues related to novel therapies for rare pediatric populations; issues related to drug pricing; monitored issues related to Right to Try including H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; monitored issues related to gene editing and gene therapy; monitored H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017.
Issues related to drug pricing; monitored issues related to Right to Try including H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; monitored issues related to gene editing and gene therapy; monitored H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017.
Monitored issues related to H.R. 2368 and H.R. 878, The Right to Try Act of 2017 and S. 204 and H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Monitored issues related to opioids and prescription drug monitoring programs.
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Issues related to drug pricing; issues related to gene editing and gene therapy; H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017; issues related to RMAT designation; issues related to value based arrangements.
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Issues related to drug pricing; issues related to gene editing and gene therapy; H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017; issues related to RMAT designation; issues related to value based arrangements.
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Issues related to novel therapies for rare pediatric populations; issues related to drug pricing; monitored issues related to Right to Try including H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; monitored issues related to gene editing and gene therapy; monitored H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017.
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Client: BLUEBIRD BIO · Firm: THE NICKLES GROUP, LLC
Issues related to drug pricing; monitored issues related to Right to Try including H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; monitored issues related to gene editing and gene therapy; monitored H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017.
CONNECT for Health Act of 2017
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, H.R. 1892, Bipartisan Budget Act of 2018 and issues regarding extension of the Independence at Home Demo, and expansion of telehealth services in certain ACOs and for individuals with stroke. Issues regarding wellness policies. Issues related to regulatory relief. H.R. 2556, the CONNECT for Health Act of 2017, regarding telehealth services for individuals with stroke. H.R. 1625, Consolidated Appropriations Act of 2018.
Medicare Access to Rural Anesthesiology Act of 2017
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment.
Medicare Access to Rural Anesthesiology Act of 2017
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment.
Medicare Access to Rural Anesthesiology Act of 2017
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment.
Medicare Access to Rural Anesthesiology Act of 2017
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
Issues related to the Independent Payment Authority Board; H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to regulatory relief; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment; H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare reimbursement.
Medicare Part B Improvement Act of 2017
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE NICKLES GROUP, LLC
H.R. 1892, Bipartisan Budget Act, H.R. 3178, Medicare Part B Improvement Act of 2017, and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to reimbursement for home infusion. Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list. H.R. 1625, Consolidated Appropriations Act of 2018.
Medicare Part B Improvement Act of 2017
Client: BAXTER HEALTHCARE CORPORATION · Firm: THE NICKLES GROUP, LLC
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, H.R. 3178, Medicare Part B Improvement Act of 2017, H.R. 1892, Bipartisan Budget Act of 2018 and issues regarding care for chronic diseases, including telehealth issues such as home as originating site and remote monitoring of home dialysis patients. Issues related to ESRD PPS. H.R. 1625, Consolidated Appropriations Act of 2018.
Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids). S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.
Monitored H.R. 6082, The Overdose Prevention and Patient Safety Act including H.R. 6, SUPPORT for Patients and Communities Act of 2018 and S. 2680, Opioid Crisis Response Act of 2018. Monitored issues related to drug shortages. Issues related to H.R. 3325, the Advancing Care for Exceptional Kids Act and Pandemic and All-Hazards Preparedness and S. 2852 / H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI).
Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids) and H.R. 7212, IMPROVE Act. S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation. H.R. 3325, Advancing Care for Exceptional Kids Act and S. 2415, Accelerating Kids' Access to Care Act.
Monitored H.R. 6082, The Overdose Prevention and Patient Safety Act including H.R. 6, SUPPORT for Patients and Communities Act of 2018 and S. 2680, Opioid Crisis Response Act of 2018. Monitored issues related to drug shortages. Issues related to H.R. 3325, the Advancing Care for Exceptional Kids Act; S. 2852 / H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI); issues related to federal funding of research.
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation. H.R. 3325, Advancing Care for Exceptional Kids Act and S. 2415, Accelerating Kids' Access to Care Act.
Overdose Prevention and Patient Safety Act
Client: CLEVELAND CLINIC FOUNDATION · Firm: THE NICKLES GROUP, LLC
Issues related to opioid abuse; monitored Alexander Murray, The Bipartisan Healthcare Stabilization Act of 2017. Monitored H.R. 3545, The Overdose Prevention and Patient Safety Act. S. 1827, KIDS Act of 2017 and H.R. 195, Extension of Continuing Appropriations Act, 2018 as they relate to reauthorizaion of CHIP.
Addiction Treatment Access Improvement Act of 2017
Client: AMERICAN SOCIETY OF ANESTHESIOLOGISTS · Firm: THE NICKLES GROUP, LLC
H.R. 6, SUPPORT for Patients and Communities Act and issues related to buprenorphine and prescribing authority for MAT. H.R. 3692, Addiction Treatment Access Improvement Act of 2017. Issues related to drug shortages. H.R. 5718, Perioperative Reduction of Opioids Act. H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act of 2018. H.R. 5197, Alternative to Opioids (ALTO) in The Emergency Department. S. 2680, The Opioid Crisis Response Act of 2018.
Monitored issues related to Right to Try including H.R. 2368 and H.R. 878, Right to Try Act of 2017, and S. 204 and H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; S. 1827, The Keep Kids' Insurance Dependable and Secure Act of 2017, H.R. 3921, HEALTHY KIDS Act and issues related to prescription drugs.
Community-Based Independence for Seniors Act of 2017
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
Issues related to Special Needs Plans and dual eligibles; H.R. 4006, Community Based Independence for Seniors Act of 2017; issues related to long term care reimbursement.
Community-Based Independence for Seniors Act of 2017
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
Issues related to Special Needs Plans and dual eligibles; S. 870, Creating High Quality Results and Outcomes Necessary to Improve CHRONIC Care Act of 2017; H.R. 4006, Community Based Independence for Seniors Act of 2017; issues related to the Part D rule.
Community-Based Independence for Seniors Act of 2017
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
Issues related to Special Needs Plans and dual eligibles; H.R. 4006, Community Based Independence for Seniors Act of 2017; issues related to long term care reimbursement.
Community-Based Independence for Seniors Act of 2017
Client: SCAN HEALTH PLAN · Firm: THE NICKLES GROUP, LLC
Issues related to Special Needs Plans and dual eligibles; H.R. 4006, Community Based Independence for Seniors Act of 2017; issues related to long term care reimbursement.
Medicare IVIG Access Enhancement Act
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE NICKLES GROUP, LLC
Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids) and H.R. 7212, IMPROVE Act. S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.
Medicare IVIG Access Enhancement Act
Client: SHIRE PHARMACEUTICALS LLC · Firm: THE NICKLES GROUP, LLC
Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids). S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.
H.R. 6, SUPPORT for Patients and Communities Act and issues related to buprenorphine and prescribing authority for MAT. H.R. 3692, Addiction Treatment Access Improvement Act of 2017. Issues related to drug shortages. H.R. 5718, Perioperative Reduction of Opioids Act. H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act of 2018. H.R. 5197, Alternative to Opioids (ALTO) in The Emergency Department. S. 2680, The Opioid Crisis Response Act of 2018.
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Client: BRISTOL-MYERS SQUIBB COMPANY · Firm: THE NICKLES GROUP, LLC
Monitored issues related to Right to Try including H.R. 2368 and H.R. 878, Right to Try Act of 2017, and S. 204 and H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; S. 1827, The Keep Kids' Insurance Dependable and Secure Act of 2017, H.R. 3921, HEALTHY KIDS Act and issues related to prescription drugs.
2019 · third_quarter · Q3
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019.
Issues related to rural anesthesiology; monitored issues related to Medicare for All.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2019 · third_quarter · Q3
Issues related to fall prevention. H.R. 3461, Community-Based Independence for Seniors Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2019 · third_quarter · Q3
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2593, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2019 · third_quarter · Q3
Issues related to the science of gene editing; issues related to the Agriculture Appropriations legislation.
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2019 · third_quarter · Q3
Monitored issues related to drug pricing; S. 2543, Prescription Drug Pricing Reduction Act of 2019 and issues related to value-based payment; issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2019 · second_quarter · Q2
Issues related to the reimbursement of CAR-T therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2019 · second_quarter · Q2
Issues related to Community Based Independence for Seniors; issues related to drug pricing and the implementation of the blueprint to lower drug prices & reduce out of pocket costs; issues related to the safe harbor protection; issues related to fall prevention. H.R. 3461, Community-Based Independence for Seniors Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2019 · second_quarter · Q2
Issues related to the regulation of laboratory developed tests and the VALID Act; monitored issues related to drug pricing; issues related to liquid biopsy; S. 1895, Lower Health Care Costs Act of 2019; H.R. 861, End Surprise Billing Act of 2019. Monitored H.R. 1765, Donald Payne Sr. Colorectal Cancer Detection Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2019 · second_quarter · Q2
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation; monitored issues related to H.R. 1839, Medicaid Services Investment and Accountability Act of 2019; issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2019 · second_quarter · Q2
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing.
Issues related to the science of gene editing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2019 · second_quarter · Q2
Issues related to rural anesthesiology; monitored issues related to Medicare for All.
Issues related to drug shortages; issues related to scope of practice; S. 1895, Lower Health Care Costs Act of 2019 and No Surprises Act discussion draft; H.R. 861, End Surprise Billing Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2019 · second_quarter · Q2
Issues regarding proposals to reduce health care costs; monitored issues related to drug pricing and drug shortages; issues related to H.R. 1839, Medicaid Investment & Accountability Act; H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI); issues related to federal funding of research. Issues related to H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act. Monitored issues related to price transparency. Monitored issues related to H.R. 3630, No Surprises Act, and S. 1895, Lower Health Care Costs Act of 2019 as it relates to surprise billing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2019 · second_quarter · Q2
Monitored issues related to pharmaceutical prices. Monitored H.R. 2296, METRIC Act of 2019. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues related to Pandemic and All-Hazards Preparedness. S. 1379 / H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPA). S. 1895, Lower Health Care Costs Act of 2019. Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. Issues related to Pandemic and All-Hazards Preparedness. H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPA); monitored issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Issues related to ESRD PPS and innovative device reimbursement policies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Issues regarding proposals to reduce health care costs; monitored issues related to drug shortages; Issues related to H.R. 1839, Medicaid Investment & Accountability Act; H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAI); issues related to federal funding of research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Issues related to the reimbursement of CAR-T therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Issues related to drug pricing; issues related to the IPI CMMI demonstration; monitored issues related to the RFI, the Blueprint to Lower Drug Prices and Reduce Out of Pocket Costs.
Issues related to drug pricing including transparency; monitored H.R. 965, the CREATES Act; monitored healthcare consolidation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing.
Issues related to the science of gene editing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Monitored issues related to the conference report accompanying H.J. Res 31.
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation; monitored issues related to H.R. 1839, Medicaid Services Investment and Accountability Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Issues related to the conference report accompanying H.J. Res 31; issues related to the impact of the government shutdown on FDA.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Issues related to drug shortages; issues related to scope of practice; issues related to out-of-network providers and surprise billing.
Monitored issues related to the conference report accompanying H.J. Res 31.
Issues related to rural anesthesiology; monitored issues related to Medicare for All.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Issues related to the regulation of laboratory developed tests and the VALID Act; monitored issues related to drug pricing; issues related to liquid biopsy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2019 · first_quarter · Q1
Issues related to Community Based Independence for Seniors; issues related to drug pricing and the implementation of the blueprint to lower drug prices & reduce out of pocket costs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via THE NICKLES GROUP, LLC
2019 · first_quarter · RR
Issues related to the reimbursement of CAR-T therapies.
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2018 · fourth_quarter · Q4
Monitored issues related to pharmaceutical prices. Monitored issues related to H.R 7217, IMPROVE Act. Issues related to ESRD payment. H.R. 6, SUPPORT for Patients and Communities Act, S. 2680, Opioid Crisis Response Act of 2018. Issues related to Pandemic and All-Hazards Preparedness, S. 2852 / H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPA); monitored issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.
Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act of 2019
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2018 · fourth_quarter · Q4
Monitored H.R. 6082, The Overdose Prevention and Patient Safety Act including H.R. 6, SUPPORT for Patients and Communities Act of 2018 and S. 2680, Opioid Crisis Response Act of 2018. Monitored issues related to drug shortages. Issues related to H.R. 3325, the Advancing Care for Exceptional Kids Act; S. 2852 / H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI); issues related to federal funding of research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2018 · fourth_quarter · Q4
H.R. 6, SUPPORT for Patients and Communities Act and S. 2680, The Opioid Crisis Response Act of 2018 and issues related to buprenorphine and prescribing authority for MAT. Issues related to drug shortages; issues related to scope of practice; issues related to out-of-network providers.
H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2018 · fourth_quarter · Q4
Issues related to Special Needs Plans and dual eligibles; H.R. 4006, Community Based Independence for Seniors Act of 2017; issues related to long term care reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2018 · fourth_quarter · Q4
H.R. 6, SUPPORT for Patients and Communities Act of 2018 and S. 2680 Opioid Crisis Response Act of 2018 and issues related to prescription drug monitoring.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SHIRE PHARMACEUTICALS LLC via THE NICKLES GROUP, LLC
2018 · fourth_quarter · 4T
Orphan Drug Act and issues regarding access to care for those with rare diseases. H.R. 5803, SAFETY Act of 2018, S. 2680, Opioid Crisis Response Act of 2018, S. 2891, Fighting the Opioid Epidemic with Sunshine Act of 2018, S. 3000, Patient Advocacy Transparency Act, and H.R. 6, SUPPORT for Patients and Communities Act as they related to issues regarding controlled substances. Monitored issues related to newborn screening.
Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act of 2019.
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2018 · fourth_quarter · Q4
Monitored issues related to drug pricing; monitored opioid legislation.
Issues related to drug pricing; issues related to Part D drug benefit; issues related to the IPI CMMI demonstration.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2018 · fourth_quarter · Q4
Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act.
Issues related to the regulation of laboratory developed tests and the VALID Act; monitored issues related to drug pricing; issues related to liquid biopsy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2018 · fourth_quarter · Q4
Issues related to the science of gene editing.
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2018 · fourth_quarter · Q4
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation. H.R. 3325, Advancing Care for Exceptional Kids Act and S. 2415, Accelerating Kids' Access to Care Act.
Issues related to drug pricing; issues related to gene editing and gene therapy; H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017; issues related to RMAT designation; issues related to value based arrangements.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
SHIRE PHARMACEUTICALS LLC via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
Orphan Drug Act and issues regarding access to care for those with rare diseases. H.R. 5803, SAFETY Act of 2018, S. 2680, Opioid Crisis Response Act of 2018, S. 2891, Fighting the Opioid Epidemic with Sunshine Act of 2018, S. 3000, Patient Advocacy Transparency Act, and H.R. 6, SUPPORT for Patients and Communities Act as they related to issues regarding controlled substances.
Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids). S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment.
H.R. 6, SUPPORT for Patients and Communities Act and S. 2680, The Opioid Crisis Response Act of 2018 and issues related to buprenorphine and prescribing authority for MAT. Issues related to drug shortages; issues related to scope of practice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
Monitored issues related to drug pricing; monitored opioid legislation.
Monitored issues related to drug pricing; issues related to Part D drug benefit. S. 2554 / H.R. 6143, Patient Right to Know Drug Prices Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation. H.R. 3325, Advancing Care for Exceptional Kids Act and S. 2415, Accelerating Kids' Access to Care Act.
Issues related to drug pricing; issues related to gene editing and gene therapy; H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017; issues related to RMAT designation; issues related to value based arrangements.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
Monitored issues related to pharmaceutical prices. Issues related to the Puerto Rico recovery efforts. Issues related to ESRD payment. H.R. 6, SUPPORT for Patients and Communities Act, S. 2680, Opioid Crisis Response Act of 2018. Issues related to Pandemic and All-Hazards Preparedness and S. 2852 / H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPA); monitored issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory.
Issues related to ESRD PPS and innovative device reimbursement policies.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
Issues regarding wellness policies. Monitored issues related to prescription drug pricing. Issues related to CAR T-cell therapy reimbursement and site neutral payment. Issues involving reimbursement for TRACK 1+ ACOs.
Monitored H.R. 6082, The Overdose Prevention and Patient Safety Act including H.R. 6, SUPPORT for Patients and Communities Act of 2018 and S. 2680, Opioid Crisis Response Act of 2018. Monitored issues related to drug shortages. Issues related to H.R. 3325, the Advancing Care for Exceptional Kids Act and Pandemic and All-Hazards Preparedness and S. 2852 / H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
Issues related to Special Needs Plans and dual eligibles; H.R. 4006, Community Based Independence for Seniors Act of 2017; issues related to long term care reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
Issues related to regulation of diagnostics; monitored issues related to drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
Issues related to the science of gene editing.
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2018 · third_quarter · Q3
Issues related to value based purchasing; issues related to reimbursement of Part B and D drugs; issues related to drug pricing.
H.R. 6, SUPPORT for Patients and Communities Act of 2018 and S. 2680 Opioid Crisis Response Act of 2018 and issues related to prescription drug monitoring; issues related to clinical trials; monitored issus related to prescription drug pricing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
Monitored issues related to S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; monitored issues related to drug pricing; monitored opioid legislation.
Monitored the FY 2019 budget resolution, H. Con. Res. 128.
Monitored issues related to drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
Monitored issues related to H.R. 2368 and H.R. 878, The Right to Try Act of 2017 and S. 204 and H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Issues related to opioids and prescription drug monitoring programs including H.R. 5812, the CONNECTIONS Act.
Issues related to value based purchasing; issues related to reimbursement of Part B and D drugs.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
H.R. 6, SUPPORT for Patients and Communities Act and issues related to buprenorphine and prescribing authority for MAT. H.R. 3692, Addiction Treatment Access Improvement Act of 2017. Issues related to drug shortages. H.R. 5718, Perioperative Reduction of Opioids Act. H.R. 5774, Combating Opioid Abuse for Care in Hospitals Act of 2018. H.R. 5197, Alternative to Opioids (ALTO) in The Emergency Department. S. 2680, The Opioid Crisis Response Act of 2018.
H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
Issues regarding wellness policies. Issues related to prescription drug pricing. Issues related to CAR T-cell therapy, including reimbursement. Issues involving reimbursement for TRACK 1+ ACOs.
Monitored H.R. 6082, The Overdose Prevention and Patient Safety Act including H.R. 6, SUPPORT for Patients and Communities Act of 2018 and S. 2680, Opioid Crisis Response Act of 2018. Monitored issues related to drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list. Issues related to opioids, including H.R. 6, SUPPORT for Patients and Communities Act.
S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017 and monitored implementation. Orphan Drug Act and issues regarding access to care for those with rare diseases. Issues regarding opioids, including H.R. 5803, SAFETY Act of 2018, S. 2680, Opioid Crisis Response Act of 2018, S. 2891, Fighting the Opioid Epidemic with Sunshine Act of 2018 and S. 3000, Patient Advocacy Transparency Act, and H.R. 6, SUPPORT for Patients and Communities Act.
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
Monitored issues related to pharmaceutical prices. Issues related to the Puerto Rico recovery efforts. Issues related to ESRD payment. H.R. 6, SUPPORT for Patients and Communities Act, S. 2680, Opioid Crisis Response Act of 2018. Issues related to Pandemic and All-Hazards Preparedness and S. 2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (PAHPAI); monitored issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory.
Issues related to ESRD PPS and innovative device reimbursement policies.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, White House Office
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
Issues related to Special Needs Plans and dual eligibles; H.R. 4006, Community Based Independence for Seniors Act of 2017; issues related to long term care reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing.
Monitored issues related to the science of gene editing.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
Issues related to regulation of diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2018 · second_quarter · Q2
Issues related to drug pricing; monitored issues related to Right to Try including H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; monitored issues related to gene editing and gene therapy; monitored H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017.
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation. Monitored S. 2415, Accelerating Kids' Access to Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
Monitored issues related to H.R. 2368 and H.R. 878, The Right to Try Act of 2017 and S. 204 and H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Monitored issues related to opioids and prescription drug monitoring programs.
Issues related to value based purchasing; issues related to reimbursement of Part B drugs; monitored H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Part D program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, H.R. 1892, Bipartisan Budget Act of 2018 and issues regarding extension of the Independence at Home Demo, and expansion of telehealth services in certain ACOs and for individuals with stroke. Issues regarding wellness policies. Issues related to regulatory relief. H.R. 2556, the CONNECT for Health Act of 2017, regarding telehealth services for individuals with stroke. H.R. 1625, Consolidated Appropriations Act of 2018.
H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare extenders and hospital reimbursement.
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
H.R. 1892, Bipartisan Budget Act of 2018 and H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare.
Monitored issues related to Alexander Murray, The Bipartisan Healthcare Stabilization Act of 2017.
Issues related to Special Needs Plans and dual eligibles; S. 870, Creating High Quality Results and Outcomes Necessary to Improve CHRONIC Care Act of 2017; H.R. 4006, Community Based Independence for Seniors Act of 2017; issues related to the Part D rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
Issues related to novel therapies for rare pediatric populations; issues related to drug pricing; monitored issues related to Right to Try including H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; monitored issues related to gene editing and gene therapy; monitored H.R. 2410/S. 2465, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017.
H.R. 1892, Bipartisan Budget Act of 2018 and issues related to Medicare reimbursement for prescription drugs; monitored H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to drug pricing; issue related to value-based pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
Issues related to value based purchasing; H.R. 1892, Bipartisan Budget Act of 2018 and H.R. 1625, Consolidated Appropriations Act of 2018, regarding drug pricing; monitored the Medicare NCD on NGS related LDT's.
H.R. 1892, Bipartisan Budget Act of 2018; H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to drug pricing.
Monitored issues related to Right to Try including H.R. 2368 and H.R. 878, Right to Try Act of 2017, and S. 204 and H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; S. 1827, The Keep Kids' Insurance Dependable and Secure Act of 2017, H.R. 3921, HEALTHY KIDS Act and issues related to prescription drugs.
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
Monitored issues related to the science of gene editing.
Issues related to reimbursement of novel therapies; monitored issue related to drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
Issues related to the Independent Payment Authority Board; H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to regulatory relief; issues related to alternative pain treatments (to opioids); telehealth issues related to pain treatment; H.R. 1892, Bipartisan Budget Act of 2018, H.R. 1625, Consolidated Appropriations Act of 2018 and issues related to Medicare reimbursement.
Issues related to the opioid crisis.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
Issues related to the Medicare NCD on Next Gen Sequencing laboratory developed tests.
Issues related to regulation of diagnostics.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017, H.R. 3178, Medicare Part B Improvement Act of 2017, H.R. 1892, Bipartisan Budget Act of 2018 and issues regarding care for chronic diseases, including telehealth issues such as home as originating site and remote monitoring of home dialysis patients. Issues related to ESRD PPS. H.R. 1625, Consolidated Appropriations Act of 2018.
Monitored issues related to pharmaceutical prices. H.R. 1625, Consolidated Appropriations Act of 2018. H.R. 1892, Bipartisan Budget Act of 2018. Issues related to the Puerto Rico recovery efforts. Issues related to ESRD payment.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
SHIRE PHARMACEUTICALS LLC via THE NICKLES GROUP, LLC
2018 · first_quarter · Q1
H.R. 1892, Bipartisan Budget Act, H.R. 3178, Medicare Part B Improvement Act of 2017, and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to reimbursement for home infusion. Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list. H.R. 1625, Consolidated Appropriations Act of 2018.
H.R. 2368, Right to Try Act. H.R. 878, Right to Try Act of 2017. H.R. 5247/ S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Issues regarding access to care for those with rare diseases.
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
Issues related to LDT's; issues related to liquid biopsies.
Issues related to Medicare reimbursement for laboratory tests.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
S. 1827, Keeping Kids' Insurance Dependable and Secure Act and the Reauthorization of CHIP; monitored issues related to opioid abuse; monitored Alexander Murray, The Bipartisan Healthcare Stabilization Act of 2017; issues related to the individual mandate; monitored H.R. 3545, The Overdose Prevention and Patient Safety Act.
H.Con.Res. 71 and issues related to corporate tax reform. H.R. 1370, An Act to amend the Homeland Security Act of 2002, as it relates to further additional appropriations for 2018 and issues related to extension of the Independence at Home Demo telehealth, and CHIP.
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
Issues related to the science of gene editing; issues related to the protection of privacy rights of genetic research participants.
H.R. 1, The Tax Cut and Jobs Act, as it relates to corporate tax reform and the orphan drug tax credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
Issues related to Medicaid and CHIP as it relates to rare pediatric diseases.
Issues related to novel therapies for rare pediatric populations; issues related to drug pricing; monitored issues related to Right to Try including H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017; monitored issues related to gene editing and gene therapy; monitored issues concerning value based contracting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
Issues related to the Independent Payment Authority Board; H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to regulatory relief.
Issues related to opioid use; issues related to regulatory relief.
H.R.1370, An Act to amend the Homeland Security Act of 2002, as it relates to further additional appropriations for 2018 and CHIP and PAYGO.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
H.R.1370, An Act to amend the Homeland Security Act of 2002, as it relates to further additional appropriations for 2018 as it relates to PAYGO and CHIP. H.Con.Res. 71 and issues related to corporate tax reform.
Issues related to drug pricing and value based purchasing.
Monitored issues related to Right to Try including H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHIRE PHARMACEUTICALS LLC via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
H.R. 1, The Tax Cut and Jobs Act, as it relates to corporate tax reform, the taxation of multinationals, and the orphan drug tax credit.
H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Issues regarding access to care for those with rare diseases.
H.R. 3178, Medicare Part B Improvement Act of 2017 and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to reimbursement for home infusion. Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list.
UCB, INC. via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
Issues related to value based purchasing; issues related to reimbursement of Part B drugs.
Monitored issues related to H.R. 2368 and H.R. 878 related to The Right to Try and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Monitored issues related to the drug supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
Issues related to Special Needs Plans and dual eligibles; S. 870, Creating High Quality Results and Outcomes Necessary to Improve CHRONIC Care Act of 2017; H.R. 4006, Community Based Independence for Seniors Act of 2017.
Monitored issues related to Alexander Murray, The Bipartisan Healthcare Stabilization Act of 2017.
H.R.1370, An Act to amend the Homeland Security Act of 2002, as it relates to further additional appropriations for 2018 and issues related to paygo and CHIP.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2017 · fourth_quarter · Q4
Monitored issues related to pharmaceutical prices. H.R. 3178, Medicare Part B Improvement Act of 2017 and S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 and issues related to telehealth such as home as originating site and remote monitoring of home dialysis patients. Issues related to the Puerto Rico recovery efforts.
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 and issues regarding care for chronic diseases, including telehealth issues such as home as originating site and remote monitoring of home dialysis patients. S. 1016 and H.R. 2556, Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2017 (CONNECT for Health Act). H.R. 3178, Medicare Part B Improvement Act of 2017 and issues regarding telehealth. Issues related to ESRD PPS.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Economic Council (NEC), SENATE
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
H.R. 1628, the American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment; issues related to drug pricing and value based purchasing.
H.R. 1628, the American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment; S.934 and H.R. 2430, The FDA Reauthorization Act of 2017. Monitor issues related to moonshot.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 regarding extension of the Independence at Home Demo and telehealth. Issues regarding wellness. Issues related to regulatory relief.
H.R. 1628, The American Health Care Act of 2017 including the Better Care Reconciliation Act and Graham Cassidy amendment; S. 1827, Keeping Kids' Insurance Dependable and Secure Act and the Reauthorization of CHIP; monitored issues related to opioid abuse; issues related to S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UCB, INC. via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
Issues related to value based purchasing; issues related to reimbursement of Part B drugs.
Monitored H.R. 1628, the American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment. S. 934 and H.R. 2430, the FDA Reauthorization Act of 2017 and issues related to scientific communication and reimportation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
Issues related to Medicare reimbursement for laboratory tests and the 14 day rule.
Monitored issues related to LDT's; issues related to liquid biopsies.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
SHIRE PHARMACEUTICALS LLC via THE NICKLES GROUP, LLC
2017 · third_quarter · 3A
H.R. 3178, Medicare Part B Improvement Act of 2017 and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to home infusion and reimbursement for infused drugs administered through DME. Issues related to pharmaceutical prices. H.R. 1628, The American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment and issues regarding access to care for those with rare diseases. H.R. 3823, The Disaster Tax Relief and Airport and Airway Extension Act of 2017, as it relates to extension of the IVIG Demo. Issues regarding the Self-Administered Drugs (SAD) list.
S. 934 / H.R. 2430, The FDA Reauthorization Act of 2017 and issues regarding right to try and clinical superiority. S. 204, Trickett Wendler Right to Try Act of 2017. H.R. 878, Right to Try Act of 2017. S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 and issues regarding care for chronic care disease patients. H.R. 1628, The American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment and issues regarding access to care for those with rare diseases.
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
Monitoring issues related to pharmaceutical prices. H.R. 3178, Medicare Part B Improvement Act of 2017 and S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 and issues related to telehealth such as home as originating site and remote monitoring of home dialysis patients. H.R. 2430 / S. 934, The FDA Reauthorization Act of 2017. S. 469, the Affordable and Safe Prescription Drug Importation Act as it relates to peritoneal dialysis solutions. Issues related to H.R. 1628, the American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment.
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 and issues regarding care for chronic diseases, including telehealth issues such as home as originating site and remote monitoring of home dialysis patients. S. 1016 and H.R. 2556, Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2017 (CONNECT for Health Act). H.R. 3178, Medicare Part B Improvement Act of 2017 and issues regarding telehealth. Issues related to H.R. 1628, the American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment.
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2017 · third_quarter · 3A
Issues related to novel therapies for rare pediatric populations; H.R. 1628, The American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment; monitored issues related to S.204, the Trickett Wendler Right to Try Act of 2017; monitored issues related to the consideration of S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017.
Issues related to Medicaid and CHIP as it relates to rare pediatric diseases. H.R. 1628, The American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment and issues related to Medicaid and high risk populations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DENTAL ASSOCIATION via THE NICKLES GROUP, LLC
2017 · third_quarter · 3A
H.R. 3219, Make America Secure Appropriations Act of 2018 as it relates to Medical Dental Research Funding. S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 and access to dental services. Monitor H. Con. Res. 71, The FY 2018 Budget Resolution, as it relates to tax reconciliation instructions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
Issues related to novel therapies for rare pediatric populations; H.R. 1628, The American Health Care Act of 2017 including the Better Health Reconciliation Act and the Graham Cassidy amendment; monitored issues related to S.204, the Trickett Wendler Right to Try Act of 2017; monitored issues related to the consideration of S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017.
Issues related to Medicaid and CHIP as it relates to rare pediatric diseases. H.R. 1628, The American Health Care Act of 2017 including the Better Health Reconciliation Act and the Graham Cassidy amendment and issues related to Medicaid and high risk populations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS LLC via THE NICKLES GROUP, LLC
2017 · third_quarter · 3A
S. 934 / H.R. 2430, The FDA Reauthorization Act of 2017 and issues regarding right to try and clinical superiority. S. 204, Trickett Wendler Right to Try Act of 2017. H.R. 878, Right to Try Act of 2017. S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 and issues regarding care for chronic care disease patients. H.R. 1628, The American Health Care Act of 2017 including the Better Health Reconciliation Act and the Graham Cassidy amendment and issues regarding access to care for those with rare diseases.
H.R. 3178, Medicare Part B Improvement Act of 2017 and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to home infusion and reimbursement for infused drugs administered through DME. Issues related to pharmaceutical prices. H.R. 1628, The American Health Care Act of 2017 including the Better Health Reconciliation Act and the Graham Cassidy amendment and issues regarding access to care for those with rare diseases. H.R. 3823, The Disaster Tax Relief and Airport and Airway Extension Act of 2017, as it relates to extension of the IVIG Demo. Issues regarding the Self-Administered Drugs (SAD) list.
SHIRE PHARMACEUTICALS LLC via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
H.R. 3178, Medicare Part B Improvement Act of 2017 and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to home infusion and reimbursement for infused drugs administered through DME. Issues related to pharmaceutical prices. H.R. 1628, The American Health Care Act of 2017 including the Better Health Reconciliation Act and the Graham Cassidy amendment and issues regarding access to care for those with rare diseases. H.R. 3823, The Disaster Tax Relief and Airport and Airway Extension Act of 2017, as it relates to extension of the IVIG Demo. Issues regarding the Self-Administered Drugs (SAD) list.
S. 934, H.R. 2430, and Public Law 115-52, The FDA Reauthorization Act of 2017 and issues regarding right to try and clinical superiority. S. 204, Trickett Wendler Right to Try Act of 2017. H.R. 878, Right to Try Act of 2017. S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 and issues regarding care for chronic care disease patients. H.R. 1628, The American Health Care Act of 2017 including the Better Health Reconciliation Act and the Graham Cassidy amendment and issues regarding access to care for those with rare diseases.
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2017 · third_quarter · 3A
H.R. 1628, the American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment; issues related to opioid use; issues related to regulatory relief.
Issues related to the Independent Payment Authority Board; H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017; issues related to regulatory relief.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN DENTAL ASSOCIATION via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
H.R. 3219, Make America Secure Appropriations Act of 2018 as it relates to Medical Dental Research Funding. S. 1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 and access to dental services. Monitor H. Con. Res. 71, The FY 2018 Budget Resolution, as it relates to tax reconciliation instructions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
Issues related to the science of gene editing.
Education efforts on the science of gene editing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SCAN HEALTH PLAN via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
Monitored H.R. 1628, the American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment.
Issues related to Special Needs Plans and dual eligibles; S. 870, Creating High Quality Results and Outcomes Necessary to Improve CHRONIC Care Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2017 · third_quarter · Q3
H.R. 1628, the American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment; issues related to opioid use; issues related to regulating relief.
Issues related to the Independent Payment Authority Board; H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHIRE PHARMACEUTICALS LLC via THE NICKLES GROUP, LLC
2017 · second_quarter · Q2
S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017 and issues regarding right to try and clinical superiority. S. 204, Trickett Wendler Right to Try Act of 2017. S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 and issues regarding care for chronic care disease patients.
Issues related to home infusion and reimbursement for infused drugs administered through DME. Issues related to pharmaceutical prices. H.R. 1628, The American Health Care Act of 2017 and issues regarding access to care for those with rare diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF ANESTHESIOLOGISTS via THE NICKLES GROUP, LLC
2017 · second_quarter · Q2
H.R. 1628, the American Health Care Act of 2017; issues related to opioid use; H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017.
H.R. 1628, the American Health Care Act of 2017. Issues related to the Independent Payment Authority Board; issues related to opioids. H.R. 2881, Medicare Access to Rural Anesthesiology Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDITAS MEDICINE via THE NICKLES GROUP, LLC
2017 · second_quarter · 2A
Issues related to innovative therapies.
CLEVELAND CLINIC FOUNDATION via THE NICKLES GROUP, LLC
2017 · second_quarter · Q2
H.R. 1628, the American Health Care Act of 2017. Monitored issues concerning opioid abuse. Monitored issues related to S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017 and Laboratory Developed Tests (LDTs).
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017; monitored issues related to telehealth; issues regarding wellness; H.R. 1628, the American Health Care Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
BAXTER HEALTHCARE CORPORATION via THE NICKLES GROUP, LLC
2017 · second_quarter · Q2
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 and issues regarding care for chronic diseases, including telehealth and remote monitoring of home health dialysis patients. Issues related to End Stage Renal Disease including reimbursement for hemodialysis. S. 1016 and H.R. 2556, Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2017 (CONNECT for Health Act).
Monitoring issues related to pharmaceutical prices. Issues related to telemedicine. H.R. 2430 and S. 934, The FDA Reauthorization Act of 2017. Monitored issues related to H.R. 1628, the American Health Care Act of 2017. S. 469, the Affordable and Safe Prescription Drug Importation Act.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
GUARDANT HEALTH via THE NICKLES GROUP, LLC
2017 · second_quarter · Q2
Issues related to Medicare reimbursement for laboratory tests.
Monitored issues related to LDT's; monitored H.R. 1628, the American Health Care Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
BLUEBIRD BIO via THE NICKLES GROUP, LLC
2017 · second_quarter · Q2
Issues related to Medicaid and CHIP as it relates to rare pediatric diseases. H.R. 1628, The American Health Care Act of 2017 and issues related to Medicaid and high risk populations.
Issues related to novel therapies for rare pediatric populations; H.R. 1628, The American Health Care Act of 2017; issues related to Medicaid and high risk populations; monitored issues related to S.204, the Trickett Wendler Right to Try Act of 2017; monitored issues related to the consideration of S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
BRISTOL-MYERS SQUIBB COMPANY via THE NICKLES GROUP, LLC
2017 · second_quarter · Q2
H.R. 1628, the American Health Care Act of 2017; issues related to drug pricing.
H.R. 1628, the American Health Care Act of 2017. S.934 and H.R. 2430, The FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
UCB, INC. via THE NICKLES GROUP, LLC
2017 · second_quarter · Q2
Monitored H.R. 1628, the American Health Care Act of 2017; monitored the User Fee legislation. S. 934 and H.R. 2430, the FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to ESRD PPS and innovative device reimbursement policies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to pharmaceutical prices. H.R. 6, SUPPORT for Patients and Communities Act; S.2680, Opioid Crisis Response Act of of 2018 and issues related to controlled substances; monitored S. 2554 / H.R. 6143, the Patient Right to Know Drug Prices Act; monitored H.R. 3325, the Advancing Care for Exceptional Kids Act (ACE Kids) and H.R. 7212, IMPROVE Act. S. 1194, Medical Nutrition Equity Act. H.R. 4724, Medicare IVIG Access Enhancement Act.
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
Issues related to opioid abuse; monitored Alexander Murray, The Bipartisan Healthcare Stabilization Act of 2017. Monitored H.R. 3545, The Overdose Prevention and Patient Safety Act. S. 1827, KIDS Act of 2017 and H.R. 195, Extension of Continuing Appropriations Act, 2018 as they relate to reauthorizaion of CHIP.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 1625, Consolidated Appropriations Act of 2018. H.R. 1892, Bipartisan Budget Act of 2018 and issues concerning the home infusion benefit.
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 regarding extension of the Independence at Home Demo and telehealth. Issues regarding wellness. Issues related to regulatory relief; issues related to wellness programs. H.R. 2556, the CONNECT for Health Act of 2017, regarding telehealth services in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE